Drug · DIN 02239028
EVISTA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since January 30, 2026; first marketed November 20, 1998.
- Drug Identification Number (DIN)
- 02239028
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Raloxifene G03XC01
- Class
- Human
- Record last updated
- February 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RALOXIFENE HYDROCHLORIDE | 60 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 6, 1998: NOC 3141New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “evista”. A notice may cover another product or only some lots: read it to see what it covers.